Similar articles

• Results of a randomized prospective trial of intraaortic balloon counterpulsation and intravenous nitroglycerin in patients with acute myocardial infarction.

  Flaherty JT, Becker LC, Weiss JL, Brinker JA, Bulkley BH, Gerstenblith G, Kallman CH, Weisfeldt ML. Flaherty JT, et al. J Am Coll Cardiol. 1985 Aug;6(2):434-46. doi: 10.1016/s0735-1097(85)80183-2. J Am Coll Cardiol. 1985. PMID: 3926848 Clinical Trial.
• A randomized clinical trial of intravenous nitroglycerin in patients with acute myocardial infarction: benefits of early treatment.

  Flaherty JT, Becker LC, Bulkley BH, Weiss JL, Gerstenblith G, Kallman CH, Pitt B, Weisfeldt ML. Flaherty JT, et al. Z Kardiol. 1983;72 Suppl 3:131-6. Z Kardiol. 1983. PMID: 6421004 Clinical Trial.
• [Experience in using nitroglycerin in the acute period of myocardial infarct].

  Mikhaĭlov AA, Lazutin VK, Zhelnov VV, Simonov VI, Giliarovskiĭ AK. Mikhaĭlov AA, et al. Kardiologiia. 1981 Dec;21(12):65-9. Kardiologiia. 1981. PMID: 6799691 Russian.
• Intravenous nitroglycerin and cardiac failure.

  Gould LA. Gould LA. N Y State J Med. 1984 Mar;84(3 Pt 1):136-9. N Y State J Med. 1984. PMID: 6425746 Review. No abstract available.
• [Some thoughts about myocardial protection (author's transl)].

  Gurtner HP, Mordasini RC. Gurtner HP, et al. Schweiz Rundsch Med Prax. 1980 Nov 4;69(44):1609-17. Schweiz Rundsch Med Prax. 1980. PMID: 6789316 Review. German. No abstract available.